# MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects

> **NCT02013388** · PHASE1 · COMPLETED · sponsor: **Nivalis Therapeutics, Inc.** · enrollment: 49 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** N91115
- **DRUG:** Placebo
- **DRUG:** N91115
- **DRUG:** Placebo-Day 1 only

## Key facts

- **NCT ID:** NCT02013388
- **Lead sponsor:** Nivalis Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2016-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02013388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02013388, "MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02013388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*